Nitrates and prodrugs (Pharmacology)

LE WE PMID CA

Nitrates and prodrugs (Pharmacology)

2000

Nitratpraeparat (Pharmakologie)

Aldehyde dehydrogenase

ALDH2

GEA3175

Guanylat cyclase

Liver (Portal hypertension)

NCX1000

NCX4016

Nitrate tolerance

Nitrates and prodrugs (Pharmacology)

Nitric oxide NO

PF9404C

Pulmonary hypertension

2006 1	Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung. [17214601] Cardiovasc Drug Rev 24(3-4): 247-60 (2006)
2006 2	Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. [16961726] Cardiovasc Drug Rev 24(2): 148-68 (2006)
2005 3	Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking properties. [16007231] Cardiovasc Drug Rev 23(2): 149-60 (2005)
2004 4	Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. [15179450] Cardiovasc Drug Rev 22(2): 135-46 (2004)
2007 5	Recent developments in nitric oxide donor drugs. [17401442] Br J Pharmacol 151(3): 305-21 (2007)
2009 6	Emerging role of nitrite in myocardial protection. [19727605] Arch Pharm Res 32(8): 1127-38 (2009)
2009 7	NO generation from inorganic nitrate and nitrite: Role in physiology, nutrition and therapeutics. [19727604] Arch Pharm Res 32(8): 1119-26 (2009)
2008 8	Nitric oxide donors: novel cancer therapeutics (review). [18949354] Int J Oncol 33(5): 909-27 (2008)
1983 9	Buccal nitroglycerin. An effective antianginal drug. [6402339] Chest 83(3): 442-3 (1983)
1981 10	Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications. [6778665] Chest 79(1): 69-76 (1981)
1979 11	Duration of action of isosorbide dinitrate. [105835] Chest 75(1): 2-4 (1979)
1978 12	Nitroglycerin and myocardial ischemia. [413694] Chest 73(1): 1-2 (1978)
2004 13	Long-term therapy with organic nitrates: the pros and cons of nitric oxide replacement therapy. [15358032] J Am Coll Cardiol 44(3): 632-4 (2004)
2009 14	New nitric oxide donors based on ruthenium complexes. [19219301] Braz J Med Biol Res 42(1): 87-93 (2009)
2010 15	Headache-type adverse effects of NO donors: vasodilation and beyond. [20331608] Br J Pharmacol 160(1): 20-35 (2010)
2009 16	Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern. [19336588] Eur Respir J 33(4): 717-21 (2009)
2009 17	Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? [20005475] Trends Cardiovasc Med 19(5): 158-64 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nitrates and prodrugs (Pharmacology).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nitrates and prodrugs (Pharmacology).php on line 92